Using Carbohydrate-Based Polymers to Facilitate Testicular Regeneration

被引:0
|
作者
Majeed, Aneeqa [1 ]
Afzal, Hanan [2 ]
Maqsood, Kaleem [3 ]
Noureen, Amara [1 ]
Gul, Zaman [3 ]
Imran, Muhammad [4 ]
Afzal, Ali [2 ,5 ]
Khawar, Muhammad Babar [1 ,6 ]
机构
[1] Univ Narowal, Dept Zool, Appl Mol Biol & Biomed Lab, Narowal, Pakistan
[2] Univ Cent Punjab, Fac Sci & Technol, Dept Zool, Mol Med & Canc Therapeut Lab, Lahore, Pakistan
[3] Univ Punjab, Inst Zool, Lahore, Pakistan
[4] Univ Punjab, Ctr Appl Mol Biol, Lahore, Pakistan
[5] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China
[6] Yangzhou Univ, Inst Translat Med, Med Coll, Yangzhou, Peoples R China
关键词
carbohydrate-based polymers; drug delivery systems; immunomodulation; stem cell therapy; testicular regeneration; POLYSACCHARIDES; MICE; HYDROGELS;
D O I
10.1111/boc.202400013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Male infertility is a significant global issue affecting 60-80 million people, with 40%-50% of cases linked to male issues. Exposure to radiation, drugs, sickness, the environment, and oxidative stress may result in testicular degeneration. Carbohydrate-based polymers (CBPs) restore testis differentiation and downregulate apoptosis genes. CBP has biodegradability, low cost, and wide availability, but is at risk of contamination and variations. CBP shows promise in wound healing, but more research is required before implementation in healthcare. Herein, we discuss the recent advances in engineering applications of CBP employed as scaffolds, drug delivery systems, immunomodulation, and stem cell therapy for testicular regeneration. Moreover, we emphasize the promising challenges warranted for future perspectives. Carbohydrate-based polymers have high mechanical strength, are biodegradable, and possess regenerative properties that aid in the regeneration of testicles via multiple methods which include drug delivery, immunomodulation, stem cell therapy, and tissue engineering. image
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Carbohydrate-based cancer vaccines
    Pan, YB
    Chefalo, P
    Nagy, N
    Harding, C
    Guo, ZW
    GLYCOBIOLOGY, 2004, 14 (11) : 1074 - 1074
  • [22] Carbohydrate-based drug delivery
    Brennan, MB
    CHEMICAL & ENGINEERING NEWS, 1997, 75 (18) : 50 - &
  • [23] Carbohydrate-based VEGF inhibitors
    Haag, Tobias
    Hughes, Richard A.
    Ritter, Gerd
    Schmidt, Richard R.
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2007, 2007 (36) : 6016 - 6033
  • [24] Carbohydrate-based nanodelivery systems
    Wang, Jun
    Li, Lingyao
    Milligan, Ian James
    Franckowiak, Emily A.
    Du, Wenjun
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [25] The carbohydrate-based drug industry
    Persidis A.
    Nature Biotechnology, 1997, 15 (5) : 479 - 480
  • [26] Carbohydrate-based liquid crystals
    Singh, Madan Kumar
    Jayaraman, N.
    Journal of the Indian Institute of Science, 2009, 89 (02) : 113 - 135
  • [27] Synthesis of carbohydrate-based antibiotics
    Wong, CH
    Bryan, MC
    Nyffeler, PT
    Liu, HT
    Chapman, E
    PURE AND APPLIED CHEMISTRY, 2003, 75 (2-3) : 179 - 186
  • [28] Carbohydrate-Based Macromolecular Biomaterials
    Su, Lu
    Feng, Yingle
    Wei, Kongchang
    Xu, Xuyang
    Liu, Rongying
    Chen, Guosong
    CHEMICAL REVIEWS, 2021, 121 (18) : 10950 - 11029
  • [29] Immunology of carbohydrate-based vaccines
    Khatun, Farjana
    Toth, Istvan
    Stephenson, Rachel J.
    ADVANCED DRUG DELIVERY REVIEWS, 2020, 165-166 : 117 - 126
  • [30] Carbohydrate-based crown ethers
    Miethchen, R
    Fehring, V
    LIEBIGS ANNALEN-RECUEIL, 1997, (03): : 553 - 561